Actively Recruiting

Age: 2Years - 18Years
All Genders
Healthy Volunteers
NCT05594706

Anhydroglucitol in Children With Type 1 Diabetes

Led by University Hospital, Geneva · Updated on 2025-04-02

60

Participants Needed

1

Research Sites

204 weeks

Total Duration

On this page

Sponsors

U

University Hospital, Geneva

Lead Sponsor

U

University of Geneva, Switzerland

Collaborating Sponsor

AI-Summary

What this Trial Is About

The investigators will measure blood levels of 1,5-anhydroglucitol in children with type 1 diabetes and correlate them with parameters related to functional beta-cell mass in diabetic patients. The values will be compared to those obtained in healthy volunteers. Children with newly diagnosed diabetes as well as children with longstanding disease will be included. The aim of the study is to test the validity of 1,5-anhydroglucitol as a novel biomarker of beta-cell mass and function in type 1 diabetes.

CONDITIONS

Official Title

Anhydroglucitol in Children With Type 1 Diabetes

Who Can Participate

Age: 2Years - 18Years
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Type 1 diabetes with positive autoantibodies against islets, insulin, islet antigen 2 (IA2), glutamic acid decarboxylase (GAD) 65, or zinc transporter (ZnT)8
  • Treatment with continuous subcutaneous insulin infusion (CSII) with or without automated insulin delivery (AID)
  • Monitoring with a continuous glucose measurement system (CGMS) or flash glucose monitor (FGM)
  • Patient willing to keep the same type of CGMS or FGM during the year of observation
  • Ability to give informed consent as documented by signature
Not Eligible

You will not qualify if you...

  • Patients treated with multiple daily injections (MDI) or not willing to wear a CGMS or FGM
  • Patients changing the type of CGMS during the course of the study

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

University Hospital of Geneva

Geneva, Canton of Geneva, Switzerland, 1211

Actively Recruiting

Loading map...

Research Team

P

Philippe Klee

CONTACT

P

Pierre Maechler

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Anhydroglucitol in Children With Type 1 Diabetes | DecenTrialz